These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30205554)

  • 1. Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma.
    Troiano G; Guida A; Aquino G; Botti G; Losito NS; Papagerakis S; Pedicillo MC; Ionna F; Longo F; Cantile M; Pennella A; Lo Russo L; Di Gioia G; Mariggiò MA; Lo Muzio L; Pannone G
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30205554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear survivin promoted by acetylation is associated with the aggressive phenotype of oral squamous cell carcinoma.
    Liu S; Shi L; Yang X; Ye D; Wang T; Dong C; Guo W; Liao Y; Song H; Xu D; Hu J; Zhang Z; Deng J
    Cell Cycle; 2017 May; 16(9):894-902. PubMed ID: 28384094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
    Zhao C; Zou H; Zhang J; Wang J; Liu H
    Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and identification of autophagy-related biomarkers for oral squamous cell carcinoma (OSCC) via integrated bioinformatics analysis.
    Huang GZ; Lu ZY; Rao Y; Gao H; Lv XZ
    J Cell Mol Med; 2021 May; 25(9):4444-4454. PubMed ID: 33837652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy.
    Freier K; Pungs S; Sticht C; Flechtenmacher C; Lichter P; Joos S; Hofele C
    Int J Cancer; 2007 Feb; 120(4):942-6. PubMed ID: 17187360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis.
    Dai JB; Zhu B; Lin WJ; Gao HY; Dai H; Zheng L; Shi WH; Chen WX
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma.
    Yang Z; Liang X; Fu Y; Liu Y; Zheng L; Liu F; Li T; Yin X; Qiao X; Xu X
    EBioMedicine; 2019 Sep; 47():44-57. PubMed ID: 31409573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative analysis of gene alterations and immunoexpression profiles of cell cycle checkpoints in oral squamous cell carcinoma.
    Pérez-Sayáns M; Chamorro-Petronacci CM; Lorenzo-Pouso AI; Peñaranda JMS; López-López J; Blanco-Carrión A; García-García A
    Cancer Biomark; 2020; 27(1):95-103. PubMed ID: 31683463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Insight into Survivin in Relevance to Hematological, Biochemical and Genetic Characteristics in Tobacco Chewers with Oral Squamous Cell Carcinoma.
    Yesupatham ST; Dayanand CD; Azeem Mohiyuddin SM; Harendra Kumar ML
    Cells; 2023 May; 12(10):. PubMed ID: 37408277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma.
    Shen S; Wang G; Shi Q; Zhang R; Zhao Y; Wei Y; Chen F; Christiani DC
    Clin Epigenetics; 2017; 9():88. PubMed ID: 28852427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear Survivin as a Prognostic Factor in Squamous-Cell Carcinoma of the Oral Cavity.
    Santarelli A; Mascitti M; Rubini C; Bambini F; Giannatempo G; Lo Russo L; Sartini D; Emanuelli M; Procaccini M; Lo Muzio L
    Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):566-570. PubMed ID: 27389554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The analysis of Survivin promoter (-31G/C) gene variation in oral squamous cell carcinoma risk and prognosis.
    Cacına C; Akgün A; Kayhan KB; Yaylım İ; Çakmakoğlu B
    J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101494. PubMed ID: 37164127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of prognostic risk prediction model of oral squamous cell carcinoma based on co-methylated genes.
    Zhu Q; Tian G; Gao J
    Int J Mol Med; 2019 Sep; 44(3):787-796. PubMed ID: 31198983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic biomarkers and therapeutic targets in oral squamous cell carcinoma: a study based on cross-database analysis.
    Yang W; Zhou W; Zhao X; Wang X; Duan L; Li Y; Niu L; Chen J; Zhang Y; Han Y; Fan D; Hong L
    Hereditas; 2021 Apr; 158(1):15. PubMed ID: 33892811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
    Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
    Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma.
    Kim YH; Kim SM; Kim YK; Hong SP; Kim MJ; Myoung H
    J Oral Pathol Med; 2010 May; 39(5):368-75. PubMed ID: 20050981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse correlation between Naa10p and Pirh2 expression and the combined prognostic value in oral squamous cell carcinoma patients.
    Zheng J; Wang F; Yang Y; Xu J; Yang J; Wang K; Liu Y; Du G; Zeng Y
    J Oral Pathol Med; 2019 Sep; 48(8):686-695. PubMed ID: 31134698
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Mumlek I; Ozretić P; Sabol M; Leović M; Glavaš-Obrovac L; Leović D; Musani V
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.